In the case of IDH1/IDH2 mutations, further development of the tumor population is directed towards diffuse astrocytoma, anaplastic astrocytoma, or oligodendroglial tumors, while EGFR, CDKN2A/B, and PTEN mutations become early driver events for the GBM (11,12). This evidence concerns the gene IDH1 and glioblastoma.